MANUFACTURERS LIFE INSURANCE COMPANY, THE - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,191
-68.0%
19,603
-53.1%
0.00%
Q1 2023$63,052
-39.6%
41,7560.0%0.00%
Q4 2022$104,390
-40.9%
41,756
-0.3%
0.00%
Q3 2022$176,763
+46.8%
41,887
-2.9%
0.00%
Q2 2022$120,386
-46.9%
43,149
+9.0%
0.00%
Q1 2022$226,512
-49.4%
39,600
-19.4%
0.00%
Q4 2021$448,000
-14.3%
49,117
+0.4%
0.00%
Q3 2021$523,000
-35.7%
48,936
-6.6%
0.00%
-100.0%
Q2 2021$813,000
+2.3%
52,415
+6.9%
0.00%0.0%
Q1 2021$795,000
-26.9%
49,038
-4.6%
0.00%0.0%
Q4 2020$1,088,000
+48.2%
51,408
+3.8%
0.00%0.0%
Q3 2020$734,000
+2.1%
49,509
-1.9%
0.00%0.0%
Q2 2020$719,000
+19.0%
50,446
-2.0%
0.00%0.0%
Q1 2020$604,000
-39.7%
51,462
+20.8%
0.00%0.0%
Q4 2019$1,001,000
+15.7%
42,592
-3.5%
0.00%0.0%
Q3 2019$865,000
+5.2%
44,135
-0.2%
0.00%0.0%
Q2 2019$822,000
-22.0%
44,222
+2.5%
0.00%0.0%
Q1 2019$1,054,000
-3.9%
43,129
+2.0%
0.00%0.0%
Q4 2018$1,097,000
-19.4%
42,292
-1.6%
0.00%0.0%
Q3 2018$1,361,000
-22.8%
42,997
-5.3%
0.00%
-50.0%
Q2 2018$1,763,000
+63.8%
45,387
+16.5%
0.00%
+100.0%
Q1 2018$1,076,000
+77.0%
38,968
+15.9%
0.00%0.0%
Q4 2017$608,000
+9.9%
33,619
-1.6%
0.00%0.0%
Q3 2017$553,000
+14.7%
34,178
-1.6%
0.00%0.0%
Q2 2017$482,000
+20.8%
34,741
+30.6%
0.00%0.0%
Q1 2017$399,000
+41.5%
26,606
+23.7%
0.00%
Q4 2016$282,000
-22.3%
21,508
+2.1%
0.00%
-100.0%
Q3 2016$363,000
-4.7%
21,067
-0.2%
0.00%0.0%
Q2 2016$381,000
+6.1%
21,104
+14.0%
0.00%
Q1 2016$359,000
-26.0%
18,519
+2.0%
0.00%
Q4 2015$485,000
+10.7%
18,151
+1.1%
0.00%
Q3 2015$438,000
-6.8%
17,952
+19.0%
0.00%
-100.0%
Q2 2015$470,000
+106.1%
15,087
-3.9%
0.00%
Q1 2015$228,000
+39.9%
15,697
-3.2%
0.00%
Q4 2014$163,000
+23.5%
16,208
+2.3%
0.00%
Q3 2014$132,000
-20.5%
15,846
+17.9%
0.00%
Q2 2014$166,00013,4390.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders